Sarah B. Mulkey

OverviewAI-generated summary

Sarah B. Mulkey's research focuses on neurological outcomes in infants and children, particularly in the context of prenatal exposures and infections. Her work investigates the impact of various conditions, including Zika virus infection, SARS-CoV-2 placentitis, and neonatal encephalopathy, on neurodevelopment. She has published research examining the long-term neurodevelopmental outcomes in children exposed to Zika virus in utero, even in the absence of observable birth defects. Additionally, her work addresses the etiology and classification of neonatal encephalopathy, aiming to move towards consensus definitions and subclassification of the condition.

Mulkey also studies the effects of medical interventions, such as transfusions, on neurodevelopmental outcomes in extremely low gestation neonates, as demonstrated by her involvement in the PENUT Trial. Her research extends to understanding the clinical-pathologic correlations of SARS-CoV-2 infection during pregnancy, including its impact on stillbirth and the role of maternal vaccination. She has also investigated the outcome of agenesis of the corpus callosum diagnosed by fetal MRI. With an h-index of 30 and over 3,100 citations across 140 publications, Mulkey is recognized as a highly cited researcher.

Metrics

• h-index: 30
• Publications: 140
• Citations: 3,102